Published On: February 21, 2022Categories: News

If you want to improve the collaboration with your patients to better control their HAE, we recommend that you advise your patients to use the new HAE TrackR app. Developed by fellow HAE patients at HAE International (HAEi), HAE TrackR is an easy-to-use electronic diary designed to record patient’s HAE attacks, treatments and the impact HAE has on their life and the life of their loved ones. In its first version HAE TrackR is available in the following languages: English, Polish, Norwegian, Swedish, Danish, Portuguese, Spanish, German and French. HAE TrackR is available as a Progressive Web Application (PWA), allowing to access a secure and GDPR compliant electronic diary from any device with a standard internet browser.

HAE TrackR at a glance – Made by patients, for patients

More Info on the HAEi TrackR app here:

  • is an easy way to track attacks, treatments, and condition
  • provides both patients and physicians with a better decision foundation for planning the management of HAE
  • protects the privacy and data of the user – the data gathered by the app is the sole property of the user and is only shared if the user decides to
  • is pharma company and product neutral
  • can be accessed from its website on a computer, tablet, or smartphone
  • will be available in as many languages as possible over time: currently

Download the app here:

Read more news from ACARE

  • December 8, 2021

    Five webinars focused on the diagnostic work-up in patients with recurrent angioedema including hereditary angioedema (HAE), therapy control and optimization. The overall aim of this webinar series is to help [...]

  • January 12, 2023

    STATE OF THE ART MANAGEMENT OF RECURRENT ANGIOEDEMA AND HANDS ON TRAINING with special focus on Canada and Europe (applied for CME) Click here to register. The overall aim of [...]

  • January 4, 2023

    Date: 04 February 2023 to 05 February 2023 Venue: Advanced Pediatrics centre, Postgraduate Institute of Medical Education and Research, Chandigarh India Eligible audience: Angioedema treating physicians, e.g. allergists, dermatologists, [...]